Real-time updates regarding the IPO of Standard Glass Lining ipo gmp: Subscriptions for Standard Glass Lining Technology Limited’s Initial Public Offering (IPO) were closed on Wednesday, January 8. The initial public offering (IPO) bidding began Monday, January 6. In addition to a new issuance of equity shares valued at ₹210 crore, the ₹410.05 crore IPO includes an Offer for Sale (OFS) of 1.43 crore equity shares by the promoters and other selling stakeholders. For the first public offering, a price range of ₹133 to ₹140 per share has been set. The equity shares of Standard Glass Lining ipo gmp Technology will be listed on the BSE and NSE.
Standard Glass Lining IPO gmp Live:
Focus Shifts to Allocation Date.
With the conclusion of the IPO’s bidding phase, focus has shifted to the allocation date. The IPO obtained a massive 182.57-time subscription by the end of the third and final day of bidding on January 8. The Qualified Institutional Buyers (QIB) category had 331.60 subscribers, the Non-Institutional Investors (NII) category had 267.99, and the Retail category had 63.99.
Key Highlights from the IPO:.
GMP Update: The Grey Market Premium (GMP) for the Standard Glass Lining initial public offering (IPO) was ₹91 per share on January 8.The IPO is expected to list for ₹231 per share, which is 65% higher than the upper price band of ₹140, according to data from Investorgain.com.
GMP reflects the willingness of investors to pay more for the public offering. It was ₹96 on January 7 and ₹91 on January 8.
The quantity of subscribers:
By the end of the bidding process, 182.57 subscriptions had been made to the IPO.
At retail, 331.60 times the QIB NII: 267.99 occasions 63.99 times
Financial Performance Snapshot:
sales Growth: The company’s sales grew from ₹240.2 crore in FY22 to ₹543.7 crore in FY24 at a compound annual growth rate (CAGR) of 50.5%.
Profit Growth: Profit After Tax (PAT) increased from ₹25.1 crore to ₹60 crore during the same time period at a compound annual growth rate (CAGR) of 55%.
EBITDA Margin: The average EBITDA margin was 17.2%, while the PAT margin was 10.7%.
A Return on Equity (RoE) of 28.5% for FY22–24 indicates strong financial stability.
Ratio of Debt to Equity: As of September 30, 2024, the net debt-to-equity ratio was 0.3x.
Milestones and Achievements:
The Glass Lining Division was created in 2013.
In 2014, 100 reactors with glass linings were sold.
2016: Delivered the first stainless steel glass-lined reactor to Natco Pharma Limited.
Revenue reached ₹500 crore in 2018.
2021: Acquired the metal business from S2 Engineering Services and the pump business from Stanpumps Engineering Industries.
2024: Acquired Hyderabad-based CPK Engineers Private Limited.
Key Selling Shareholders in the OFS:
52,04,000 S2 Engineering Services stock shares
Kandula Ramakrishna: 28,70,651 shares
24,01,716 shares of Kandula Krishna Veni’s stock
Nageshwar Rao, Kandula: 7,65,000 shares
Typical Stock Holdings: 5,04,000 Shares
Company Overview:.
Standard Glass Lining ipo gmp Technology is a manufacturer of specialist technical equipment for the chemical and pharmaceutical sectors.
Types of Products:
Plant Engineering Production Plants, Systems for Reaction Storage, Separation, and Drying Services: has eight facilities in Hyderabad that span 4 lakh square feet and have the ability to construct reactors, receivers, and storage tanks with capacities varying from 30 to 40,000 liters.
Plans for Expansion: The objective is to enter the 150mm thickness market, with a focus on industries such as heavy engineering, food oils, and oil and gas.
Strategic Alliances: We collaborated with Asahi Glassplant Inc. and GL Hakko Co. Ltd., both based in Japan, for supply and specialty glass sourcing.
Valuation and Recommendation:
With a high price range of ₹140, SGLTL is available at a P/E ratio of 38.5x (FY25 annualized earnings). This is reasonably priced in comparison to its rivals. Geojit Financial suggests investing in the IPO for medium- to long-term profits due to the company’s consistent revenue growth, robust margins, and growing demand for glass-lined equipment in the chemical and pharmaceutical industries.
